Versor Investments’s Integra LifeSciences IART Stock Holding History

Versor Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,700	Closed	-$612K	–	854
2024 Q3	$612K	Buy	+33,700	New	+$781K	0.1%	353
2023 Q2	–	Sell	-4,694	Closed	-$269K	–	721
2023 Q1	$269K	Sell	4,694 -780	-14%	-$44K	0.04%	534
2022 Q4	$307K	Sell	5,474 -2,951	-35%	-$150K	0.03%	501
2022 Q3	$357K	Sell	8,425 -173	-2%	-$8.86K	0.02%	548
2022 Q2	$465K	Buy	8,598 +3,473	+68%	+$209K	0.02%	500
2022 Q1	$329K	Buy	5,125 +1,825	+55%	+$120K	0.01%	462
2021 Q4	$221K	Buy	+3,300	New	+$223K	0.01%	479
2020 Q2	–	Sell	-6,800	Closed	-$304K	–	253
2020 Q1	$304K	Buy	+6,800	New	+$357K	0.02%	173
2019 Q3	–	Sell	-5,400	Closed	-$302K	–	311
2019 Q2	$302K	Buy	+5,400	New	+$278K	0.02%	242

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Versor Investments's IART Position: Q4 2024 in Review

Versor Investments sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 33,700 shares — an estimated $612K sold.

Versor Investments first reported a position in IART in Q2 2019 and held it in 9 quarters. The position peaked at $612K in Q3 2024. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

Versor Investments reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
Versor Investments sold 33,700 Integra LifeSciences shares in Q4 2024, an estimated $612K.
Versor Investments first reported a position in Integra LifeSciences in Q2 2019 and held it in 9 quarters.
Versor Investments's Integra LifeSciences position peaked at $612K in Q3 2024.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on Versor Investments's 13F filing for Q4 2024, filed 5 Feb 2025.